The company's strategic moves appear to be setting the stage for sustained progress in the treatment of Demodex blepharitis. While analysts project continued sales growth, detailed financial ...

The biotech sector witnessed a see-saw performance in 2024. While the year started on a positive note, much of the gains ...

Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as ...

The company's strategic moves appear to be setting the stage for sustained progress in the treatment of Demodex blepharitis. While analysts project continued sales growth, detailed financial ...

Watch on LiveTube Now 👉 Video: Betsy Sodaro Lands Her Most Unique Role Yet: an Eye Mite! #Ad ET teamed up with ‘Ghosts’ star ...